Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.